All News
The Lancet Healthy Longevity•September 17, 2026•Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Aayushka Baral, Jagadish K Chhetri, Meghnath Dhimal

Extreme Heat Amplifies Polypharmacy Risk in Older Adults

A Lancet Healthy Longevity comment identifies medication safety as a neglected dimension of climate risk in older adults. Extreme heat, power failure, displacement, and pharmaceutical supply-chain disruption compromise the ability to access, store, and safely use medicines, while age-related physiology, multimorbidity, and polypharmacy magnify the consequences. The authors position medication safety as a core component of climate adaptation for ageing populations.

Key Points

  • Extreme heat interacts with common drugs to impair thermoregulation and hydration
  • Polypharmacy, frailty, and cognitive impairment multiply climate-related medication harm
  • Power loss and supply disruption compromise drug storage, access, and continuity

Longevity Analysis

Heat stress and pharmacology converge on the same control points: fluid balance, kidney clearance, blood pressure regulation, and the body's capacity to shed heat. Anticholinergics, diuretics, beta-blockers, and psychotropics each blunt one of these responses, so a drug regimen that is well tolerated at 20°C can become a source of interference at 38°C. Periodic deprescribing review, storage planning, and attention to early signals of dehydration or cognitive change represent low-cost adaptations with direct bearing on survival and functional independence in later decades.

Temperature · Hydration · Circulation · Detoxification · Nervous SystemEliminate · Decode · Execute
Read Original Article

Original published by The Lancet Healthy Longevity, by Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Aayushka Baral, Jagadish K Chhetri, Meghnath Dhimal.